English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 天
Vivani Medical GLP-1植入剂临床试验取得进展
与此同时,Vivani已在澳大利亚开始了LIBERATE-1临床试验,用于其艾塞那肽植入剂,这标志着肥胖治疗的重大进展。该试验将评估植入剂的安全性、耐受性和药代动力学,预计将于2025年年中获得初步数据。H.C.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Senate passes funding bill
Sworn in as Canada's PM
Second protester arrested
Texas measles outbreak
Strikes deal with DOGE
SpaceX launches Crew-10
Wins longest-ever Iditarod
Plane engine catches fire
Man hit by motorcade, dies
Consumer sentiment drops
‘Ted Lasso’ is coming back
Visits DOJ for speech
Gold rises to new heights
Laceration hazard recall
Pleads not guilty
Trump Tower protest
Influencer leaves Australia
Hamas to release hostage
Smishing scam warning
FDA, NIH nominees advance
Swatting call about gunman
To cut 2,000+ jobs
$3B deal to extend rights
UN report accuses Israel
Influential WY senator dies
Senate confirmation hearing
To host Golden Globes
March megastorm
Permanently shuts route
Top intelligence agency visit
Teixeira pleads guilty
Legendary sportswriter dies
Coffee creamer recall
反馈